Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Systems

September 2009 | 110 pages | ID: D3F3ECFCFC6EN
Kalorama Information

Abstracts

With pharmaceutical companies increasingly looking for ways to extend the revenue-earning lifetime of their biggest products, drug delivery has become an important focus of the industry. Kalorama’s Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Systems provides detail for business planners on the market for implantable / injectable delivery system markets.

Biopharmaceutical products are driving growth of needle-free systems; there will likely be significant increases in revenues in the vaccine arena. This report looks at that trend and reports current and forecasted revenues for the implantable/injectable drug delivery market, segmented into two main categories:

• Needle-free drug delivery
• Other Injectable/Implantable

Kalorama's unique analysis offers segmentation of this market for:

• Drug Delivery Techology Revenues
• Pharmaceuticals Sold via Delivery Technology

This breakout makes the report relevant to business plans of either device technology companies or pharmaceutical concerns. (This market analysis does not include drug-eluding stents or prefilled or regular syringes. Kalorama considers these seperate markets)

With pharmaceutical companies increasingly turning to drug delivery to extend the revenue-earning lifetime of their biggest products, drug delivery has become an important focus of the pharmaceutical industry.

Kalorama’s Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Systems, the second volume of Kalorama’s popular series focusing on global drug delivery systems markets, provides the definitive break down of the market for implantable / injectable delivery system markets. The report covers both pharmaceuticals sold through implantable/injectable delivery systems and the technologies themselves including:

This focused report provides information on the revenues for relevant companies and provides information critical to assessing the opportunities available in this market, including:

• Detailed Profiles of Key Companies in Implantable/Injectable Delivery and Brief Round-Up of smaller players
• Current Market Size and Forecasts to 2013
• Needle-Free Cost Savings, Protein-Coated Microcrystal Technology, Nanotechnology, and Other Trends and Developments
• New Products in Development

Kalorama’s trusted information-gathering process provides most accurate study of the implantable/injectable delivery drug market available today. Information and analysis presented in this report is based on extensive interviews with senior management of top companies in the industry. While major research literature and government information is culled, information is corroborated and key market insights originate from interviews with industry leaders.

Companies Profiled in the report include:

• Alkermes, Inc.
• ALZA Corp.
• Antares Pharma, Inc.
• Bioject Medical Technologies, Inc.
• CyDex, Inc.
• MGI Pharma, Inc
• Nektar Therapeutics
• Pacira Pharmaceuticals, Inc.
• pSivida
• SurModics, Inc
• Zogenix Corporation
• AP Pharma
• Baxter BioPharma Solutions
• QLT USA, Inc
• Ypsomed Holding AG

Kalorama has also published Drug Delivery Markets: Oral Delivery, which details markets for oral technology enhancements which have increased drug product sales and extended patent life.

Contents

CHAPTER ONE: EXECUTIVE SUMMARY

Market Drivers

Market Size and Growth

Total Implantable/Injectable Drug Delivery Marke

The Implantable/Injectable Drug Delivery Only Market

Competitor and Market Analysis

CHAPTER TWO: INTRODUCTION

Scope and Methodology

Reasons for Injectable/Implantable Drug Delivery Systems

History of Injectable/Implantable Drug Delivery

Phases of Drug Action

Needle-Free Drug Delivery

Auto-injectors

Pen Injectors

Major Applications

Safety Concerns

Products

Implantable Drug Delivery

Mechanisms

Applications

Products

Sustained-Release Drug Delivery

Products

Targeted Injection Drug Delivery

Products

Lipsome

Niosome

Microspheres and Nanoparticles

Cyclodetrins

Prodrug

Polymeric Micelles

PEGylation

CHAPTER THREE: TRENDS AND DEVELOPMENTS

Drivers of the Implantable/Injectable Drug Delivery Market

Biologics

Cancer

Pen Injectors

Proprietary Product Development

Delivery Systems Placement Trends

Therapeutic Trends

Incorporation of Technology

Nanotechnology

Drug Delivery Development

Microsphere Technology

Targeted Technology

MicroChip Technology

Protein-Coated Microcrystal Technology

Needle-Free Delivery Development

Selected Products in Development

CHAPTER FOUR: MARKET SIZE AND GROWTH

The Total Implantable/Injectable Drug Delivery Market

Injectable/Implantable Delivery Technology Only Market

CHAPTER FIVE: COMPETITIVE AND MARKET ANALYSIS

Competitive Landscape

Market Analysis

CHAPTER SIX: COMPANY PROFILES

Alkermes, Inc.

ALZA Corp.

Antares Pharma, Inc.

Bioject Medical Technologies, Inc.

CyDex, Inc.

MGI Pharma, Inc

Nektar Therapeutics

Pacira Pharmaceuticals, Inc.

pSivida

SurModics, Inc

Zogenix Corporation

COMPANIES IN BRIEF

AP Pharma

Baxter BioPharma Solutions

QLT USA, Inc

Ypsomed Holding AG

APPENDIX: COMPANY DIRECTORY

TABLE OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

Figure 1-1 The Worldwide Market for Implantable/Injectable Drug Delivery Technology and Pharmaceuticals 2003-201

CHAPTER TWO: INTRODUCTION

Table 2-1 Sequence of Drug Action

Table 2-2 Marketed Products Using Liposomal Drug Delivery

Table 2-3 Marketed Products Using Nanoparticle Drug Delivery

CHAPTER THREE: TRENDS AND DEVELOPMENTS

Table 3-1 Select Products in Development by Drug Delivery Companies

CHAPTER FOUR: MARKET SIZE AND GROWTH

Table 4-1 The Worldwide Market for Implantable/Injectable Drug Delivery Technology and Pharmaceuticals 2003-2013

Figure 4-1 The Worldwide Market for Implantable/Injectable Drug Delivery Technology and Pharmaceuticals 2003-2013

Table 4-2 The Worldwide Market for Pharmaceuticals Utilizing Injectable/Implantable Drug Delivery by Type 2003-2013

Figure 4-2 The Worldwide Market for Pharmaceuticals Utilizing Injectable/Implantable Drug Delivery by Type 2003-2013

Table 4-3 The Worldwide Market for Pharmaceuticals Utilizing Injectable/Implantable Drug Delivery Market Share by Type 2003-2013

Figure 4-3 The Worldwide Market for Pharmaceuticals Utilizing Injectable/Implantable Drug Delivery Market Share by Type 2008

Figure 4-4 The Worldwide Market for Pharmaceuticals Utilizing Injectable/Implantable Drug Delivery Market Share by Type 2013

Table 4-4 The Worldwide Market for Injectable/Implantable Drug Delivery Systems by Pharmaceutical and Drug Delivery Component 2003-2013

Table 4-5 The Worldwide Market for Injectable/Implantable Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2003-2013

Figure 4-5 The Worldwide Market for Injectable/Implantable Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2008

Figure 4-6 The Worldwide Market for Injectable/Implantable Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2013

CHAPTER FIVE: COMPETITIVE AND MARKET ANALYSIS

Table 5-1 Leading Suppliers of Implantable/Injectable Drug Delivery Technology

Figure 5-1 Cost per Million Injections by Injector Type